Institutional investors purchased a net $88.5 thousand shares of NYMX during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 1.76% of the shares outstanding that institutional investors hold is among the lowest in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BMO ASSET MANAGEMENT, INC. Bought 10.0 Thousand shares of Nymox Pharmaceutical Corp